Medical Research
(H12)
990 on File
SOUTHERN CALIFORNIA LYMPHOMA GROUP INC
Financial strength (30%)
70/100
Reliability (20%)
55/100
Effectiveness (25%)
21/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$124K
Total Revenue
$53K
Total Expenses
$329K
Net Assets
N/A
Employees
Expense Breakdown
Program Expense Ratio
50.1%
Fundraising Efficiency
N/A
Operating Reserve
74.20x
Liability-to-Asset
0.0%
Revenue Diversification
N/A
Executive Compensation
$0
Compared with Peers
FY 2025
Compared with 378 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
50.1% | 75.9% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
74.2 mo | 44.2 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
51.2% | 2.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
23.9% | -2.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
57.1% | 20.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $124K | $53K | $329K | 50.1% | — |
| 2024 | $82K | $43K | $258K | 50.0% | — |
| 2023 | $38K | $18K | $219K | 50.1% | — |
| 2022 | $0 | $4K | $199K | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.